Andrew Muranyi

852 total citations · 1 hit paper
11 papers, 624 citations indexed

About

Andrew Muranyi is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Andrew Muranyi has authored 11 papers receiving a total of 624 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hematology, 7 papers in Molecular Biology and 2 papers in Oncology. Recurrent topics in Andrew Muranyi's work include Acute Myeloid Leukemia Research (9 papers), RNA modifications and cancer (2 papers) and Cell Adhesion Molecules Research (2 papers). Andrew Muranyi is often cited by papers focused on Acute Myeloid Leukemia Research (9 papers), RNA modifications and cancer (2 papers) and Cell Adhesion Molecules Research (2 papers). Andrew Muranyi collaborates with scholars based in Canada, Germany and Malaysia. Andrew Muranyi's co-authors include Donna E. Hogge, Florian Kuchenbauer, Bob Argiropoulos, R. Keith Humphries, Martin Hirst, Ryan D. Morin, Sandy Sung, Richard A. Wells, Marco A. Marra and Aly Karsan and has published in prestigious journals such as Nature Medicine, Blood and Leukemia.

In The Last Decade

Andrew Muranyi

10 papers receiving 615 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Identification of miR-145 and miR-146a as mediators of the 5q– syndrome phenotype

2009 507 citations Daniel T. Starczynowski, Florian Kuchenbauer et al. Nature Medicine profile →

Peers

Countries citing papers authored by Andrew Muranyi

Since Specialization

Citations

This map shows the geographic impact of Andrew Muranyi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Muranyi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Muranyi more than expected).

Fields of papers citing papers by Andrew Muranyi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Muranyi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Muranyi. The network helps show where Andrew Muranyi may publish in the future.

Co-authorship network of co-authors of Andrew Muranyi

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Muranyi. A scholar is included among the top collaborators of Andrew Muranyi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Muranyi. Andrew Muranyi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	Alberta Spinal Muscular Atrophy Newborn Screening—Results from Year 1 Pilot Project 2023 ·International Journal of Neonatal Screening ·(unknown), (unknown), (unknown), Christine Walker, (unknown), (unknown), Stacey Hume, Jillian S. Parboosingh, Margaret Lilley, Hanna Kolski, Ross Ridsdale, Andrew Muranyi, Jean K. Mah, Dennis E. Bulman	9
2	Npm1 haploinsufficiency in collaboration with MEIS1 is sufficient to induce AML in mice 2022 ·Blood Advances ·Andrew Muranyi, (unknown), (unknown), Vijay P.S. Rawat, Amit Kumar Sinha, Irene González-Menéndez, Leticia Quintanilla-Martı́nez, (unknown), Çagatay Güneş, Annalisa Mupo, George S. Vassiliou, (unknown), Christian Buske	3
3	GPR56 contributes to the development of acute myeloid leukemia in mice 2016 ·Leukemia ·Deidre Daria, (unknown), Andrew Muranyi, Medhanie Mulaw, (unknown), (unknown), (unknown), Lars Bullinger, Konstanze Döhner, Hartmut Döhner, Michaela Feuring‐Buske, Christian Buske	31
4	Targeting integrin linked kinase and FMS-like tyrosine kinase-3 is cytotoxic to acute myeloid leukemia stem cells but spares normal progenitors 2010 ·Leukemia Research ·Andrew Muranyi, Shoukat Dedhar, Donna E. Hogge	20
5	Mir-223 Is Dispensable for the Onset of Acute Myeloid Leukemia 2010 ·Blood ·Florian Kuchenbauer, Tobias Berg, Sarah M Mah, (unknown), (unknown), Jens Rüschmann, Andrew Muranyi, (unknown), A. MAUREEN ROUHI, Daniel T. Starczynowski, Michael Heuser, Donna E. Hogge, Fernando D. Camargo, Hartmut Döhner, Christian Buske, R. Keith Humphries	1
6	Linkage of the potent leukemogenic activity of Meis1 to cell-cycle entry and transcriptional regulation of cyclin D3 2010 ·Blood ·Bob Argiropoulos, Eric Yung, Ping Xiang, (unknown), Florian Kuchenbauer, Lars Palmqvist, Carola Reindl, Michael Heuser, Sanja Sekulovic, Patty Rosten, Andrew Muranyi, (unknown), Mark Featherstone, R. Keith Humphries	24
7	Combined inhibition of integrin linked kinase and FMS-like tyrosine kinase 3 is cytotoxic to acute myeloid leukemia progenitor cells 2009 ·Experimental Hematology ·Andrew Muranyi, Shoukat Dedhar, Donna E. Hogge	27
8	Identification of miR-145 and miR-146a as mediators of the 5q– syndrome phenotype breakdown → 2009 ·Nature Medicine ·Daniel T. Starczynowski, Florian Kuchenbauer, Bob Argiropoulos, Sandy Sung, Ryan D. Morin, Andrew Muranyi, Martin Hirst, Donna E. Hogge, Marco A. Marra, Richard A. Wells, Rena Buckstein, Wan L. Lam, R. Keith Humphries, Aly Karsan	507
9	QLT0267, a Small Molecule Inhibitor of ILK and FLT3 Is Cytotoxic to Acute Myeloid Leukemia (AML) ‘Stem Cells’ Detected in Immunodeficient Mice. 2008 ·Blood ·Andrew Muranyi, Shoukat Dedhar, Donna E. Hogge	1
10	Identification of Mir-145 and Mir-146a as Micrornas Involved in the Pathogenesis of 5q- Syndrome 2008 ·Blood ·Daniel T. Starczynowski, Florian Kuchenbauer, Bob Argiropoulos, Sandy Sung, Ryan D. Morin, Andrew Muranyi, Martin Hirst, Donna E. Hogge, Marco A. Marra, Richard A. Wells, Wan L. Lam, R. Keith Humphries, Aly Karsan	0
11	Integrin Linked Kinase Is Expressed in Acute Myeloid Leukemia Blasts and Its Inhibition Is Cytotoxic to Leukemic Progenitors. 2006 ·Blood ·Andrew Muranyi, (unknown), Donna E. Hogge	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact